Durham, NCNCT04921917Now EnrollingIRB Ready

Soft Tissue Sarcoma Clinical Trial in Durham, NC

Access cutting-edge soft tissue sarcoma treatment through this clinical trial at a research site in Durham. Study-provided care at no cost to qualified participants.

Sponsored by Duke University

Quick Self-Assessment

See if you qualify for this Durham location

Preparing your pre-screening questions…

Expert Care in Durham

Access soft tissue sarcoma specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related soft tissue sarcoma treatment provided free

Apply for This Durham Location

Check if you qualify for this soft tissue sarcoma clinical trial in Durham, NC

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Durham

    Convenient for NC residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Durham site if eligible
  4. 4Begin participation

About This Soft Tissue Sarcoma Study in Durham

The purpose of this study is to evaluate the effect of a neoadjuvant (i.e. pre-treatment) exercise regimen on extremity function and postoperative wound healing. The study group will include patients with a primary diagnosis of soft tissue sarcoma undergoing treatment with neoadjuvant radiation therapy and surgical resection. Patients with upper or lower extremity sarcomas will be considered for enrollment.

Sponsor: Duke University

Who Can Participate

Inclusion Criteria

Males and females within the ages of 18-85
Diagnosis of soft tissue sarcoma that has been histologically confirmed by an approved reference pathologist
Sarcoma of the upper or lower extremity location
Treatment plan that includes neo-adjuvant radiation therapy followed by surgical resection
Expected primary wound closure performed at the time at surgery
Any disease stage
Any tumor grade
Any histologic subtype
First or recurrent presentations
No vascular invasion or resection/repair/reconstruction that results in decreased perfusion of the extremity
No history of radiation therapy to the tumor and/or surgical area prior to the current treatment being studied
Must be able to comply with follow up visits
Must be able to provide own consent

Exclusion Criteria

Patients under the age of 18, or over the age of 85
Treatment plan that does not include neo-adjuvant radiation and surgical excision
Sarcoma location other than the upper or lower extremity
History of radiation therapy to the tumor and/or surgical area prior to the current treatment being studied
High dose steroid therapy (defined as \>5mg prednisone, or equivalent, with the last 30 days)
Active treatment with chemotherapy within the last 30 days
Inability of the patient to provide informed consent (i.e. dementia, cognitive impairment, non-English speakers)
Plan for post-operative radiation therapy
Underlying severe cardiopulmonary disease
Prior surgery, other than a biopsy, at the site of disease
Tumors that are ulcerative or fungating through the dermis at the time of presentation
Vascular invasion or resection/repair/reconstruction that results in decreased perfusion of the extremity
Vascular disease resulting in clinically apparent compromise in blood flow to the treatment extremity (i.e. peripheral vascular disease with diminished pulses, venous insufficiency with clinical evidence of vascular congestion)
Actively uncontrolled diabetes mellitus (documentation of history of Diabetes with A1c\>8)
Active deep vein thrombosis in the treatment extremity
Inability to comply with follow up visits
Pregnant females (women of childbearing potential must have a negative serum pregnancy test prior to enrollment)

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Durham?

Yes, this clinical trial (NCT04921917) has an active research site in Durham, NC that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Soft Tissue Sarcoma Treatment Options in Durham, NC

If you're searching for soft tissue sarcoma treatment options in Durham, NC, this clinical trial (NCT04921917) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Durham research site is actively enrolling participants for this clinical trial. You'll receive care from experienced soft tissue sarcoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all soft tissue sarcoma clinical trials near you to find additional studies recruiting in your area.

More Sarcoma Trials in Durham, NC

See all sarcoma clinical trials recruiting in Durham — not just this study.

Browse Sarcoma Trials in Durham →

Browse More Trials by Condition

Sarcoma TrialsSarcoma Soft Tissue TrialsAll Conditions →

Ready to Join in Durham?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Durham, NC